ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
34.65
-0.26%
US Tech 100
19,168.00
0.52%
S&P 500
5,431.60
-0.04%
US Dollar vs CAD
1.37515
0.00%
Bitcoin
66,287.20
0.14%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Magenta Therapeutics Inc (MGTA)

  7. Magenta Therapeutics Inc (MGTA) News

MGTA

Magenta Therapeutics (MGTA)

Magenta Therapeutics Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:MGTA
DateTimeSourceHeadlineSymbolCompany
06/06/20247:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20247:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20247:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20247:04PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20247:02PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20246:59PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20246:58PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20246:57PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
05/28/20244:24PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
05/28/20244:20PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
05/09/20243:27PMEdgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:MGTAMagenta Therapeutics Inc
05/09/20243:20PMEdgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:MGTAMagenta Therapeutics Inc
05/09/20243:08PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
04/11/20243:10PMEdgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:MGTAMagenta Therapeutics Inc
04/11/20243:09PMEdgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:MGTAMagenta Therapeutics Inc
04/11/20243:05PMEdgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:MGTAMagenta Therapeutics Inc
04/01/20245:34PMEdgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
04/01/20245:21PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
03/27/202411:15PMEdgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:MGTAMagenta Therapeutics Inc
03/21/20244:10PMEdgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:MGTAMagenta Therapeutics Inc
03/21/20244:02PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
03/21/20243:07PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:MGTAMagenta Therapeutics Inc
03/21/20243:04PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:MGTAMagenta Therapeutics Inc
02/14/20243:16PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/09/20243:10PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/07/20243:52PMEdgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:MGTAMagenta Therapeutics Inc
02/02/20243:32PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:MGTAMagenta Therapeutics Inc
01/31/202411:11AMEdgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:MGTAMagenta Therapeutics Inc
01/26/20243:46PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
01/26/20243:43PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:MGTAMagenta Therapeutics Inc
 Showing the most relevant articles for your search:NASDAQ:MGTA

Your Recent History

DBI
3BTT
General All Share Kurs
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved